Lakefront Biotherapeutics (LKFT) Other financing activities (2014 - 2020)
Lakefront Biotherapeutics (LKFT) posted quarterly Other financing activities of $2.6 billion for Q2 2020, up 103.58% year-over-year from $1.3 billion in Q3 2019, and up 707796.13% quarter-over-quarter from $370923.5 in Q1 2020.
Lakefront Biotherapeutics (LKFT) Other financing activities (2014 - 2020) Analysis & Trends
Lakefront Biotherapeutics (LKFT) has reported Other financing activities for 5 consecutive years, with $2.6 billion the latest figure, recorded in Q2 2020.
- In Q2 2020, Other financing activities rose 103.58% year-over-year to $2.6 billion; the TTM figure through Jun 2020 stood at $2.6 billion (up 98.23% YoY), while the FY2017 annual figure was $7.7 million, up 2855.82% from the prior year.
- Other financing activities advanced to $2.6 billion in Q2 2020 per LKFT's latest filing, from $370923.5 in the prior quarter.
- Across five years, Other financing activities topped out at $7.2 billion in Q2 2017 and bottomed at -$7.7 billion in Q3 2017.
- Historically, Other financing activities has averaged $181.2 million across 4 years, with a median of $3.7 million in 2017.
- Annual changes were most pronounced in 2018 — Other financing activities tumbled 98.91% — and 2020, when it jumped 379.91%.
- Lakefront Biotherapeutics' Other financing activities stood at $7.7 million in 2017, then tumbled by 16240.65% to -$1.2 billion in 2018, then retreated by 4.41% to -$1.3 billion in 2019, then soared by 302.62% to $2.6 billion in 2020.
- Business Quant data shows LKFT's Other financing activities at $2.6 billion in Q2 2020, $370923.5 in Q1 2020, and -$1.3 billion in Q3 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Lakefront Biotherapeutics | 1.81 Bn | -1.68 Bn | 1.97 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2020 | 2.63 Bn |
| Jun 30, 2020 | 2.63 Bn |
| Mar 31, 2020 | 370,923.51 |
| Mar 31, 2020 | 370,923.51 |
| Sep 30, 2019 | -1.30 Bn |
| Sep 30, 2019 | -1.30 Bn |
| Jun 30, 2019 | 1.29 Bn |
| Jun 30, 2019 | 1.29 Bn |
| Mar 31, 2019 | 77,290.76 |
| Mar 31, 2019 | 77,290.76 |
| Sep 30, 2018 | -1.24 Bn |
| Sep 30, 2018 | -1.24 Bn |
| Jun 30, 2018 | 1.27 Bn |
| Jun 30, 2018 | 1.27 Bn |
| Mar 31, 2018 | 76,169.03 |
| Mar 31, 2018 | 76,169.03 |
| Dec 31, 2017 | 7.69 Mn |
| Dec 31, 2017 | 7.69 Mn |
| Sep 30, 2017 | -7.67 Bn |
| Sep 30, 2017 | -7.67 Bn |